Genomma Lab Internacional SAB de CV (LABB) - Financial and Strategic SWOT Analysis Review

June 2020 | 41 pages | ID: GF67A301BCDEN
GlobalData

Abstracts

Genomma Lab Internacional SAB de CV (LABB) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:

• Business description – A detailed description of the company’s operations and business divisions.
• Corporate strategy – Analyst’s summarization of the company’s business strategy.
• SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
• Company history – Progression of key events associated with the company.
• Major products and services – A list of major products, services and brands of the company.
• Key competitors – A list of key competitors to the company.
• Key employees – A list of the key executives of the company.
• Executive biographies – A brief summary of the executives’ employment history.
• Key operational heads – A list of personnel heading key departments/functions.
• Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
• Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
• Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

Genomma Lab Internacional SAB de CV (Genomma Lab) carries out the research, manufacture and commercialization of pharmaceuticals and other healthcare products. Its product portfolio includes wellness products, personal care products, dermo-cosmetic products and other healthcare products. The company offers anti-acne products, scar removal ointments, anti-acids, varicose vein treatments, analgesics, anti-fungal products, anti-inflammatory products, multivitamins, stress management products, osteoarthritis treatments, hair loss treatments, hemorrhoid treatments, colitis treatment products, shampoos, flu treatments and other products. It offers products in Mexico, Latin America and the US, among others. Genomma Lab is headquartered at Mexico City, Mexico.

Genomma Lab Internacional SAB de CV Key Recent Developments

Apr 22,2020: Genomma Lab Internacional reports first quarter 2020 results
Feb 26,2020: Genomma Lab reports fourth quarter & full year 2019 results
Oct 23,2019: Genomma Lab internacional reports third quarter 2019 results
Sep 30,2019: Genomma Lab Internacional Informs Total Prepayment Of Local Bond (CEBUR) LAB 14
Jul 24,2019: Genomma Lab Internacional reports second quarter 2019 results

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.

• The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.

• The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.

• Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.

• Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.

• Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

Contents

SECTION 1 - ABOUT THE COMPANY

Genomma Lab Internacional SAB de CV - Key Facts
Genomma Lab Internacional SAB de CV - Key Employees
Genomma Lab Internacional SAB de CV - Major Products and Services
Genomma Lab Internacional SAB de CV - History
Genomma Lab Internacional SAB de CV - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries

SECTION 2 – COMPANY ANALYSIS

Company Overview
Genomma Lab Internacional SAB de CV - Business Description
Geographical Segment: International
Performance
Geographical Segment: Mexico
Performance
Genomma Lab Internacional SAB de CV - SWOT Analysis
SWOT Analysis - Overview
Genomma Lab Internacional SAB de CV - Strengths
Genomma Lab Internacional SAB de CV - Weaknesses
Genomma Lab Internacional SAB de CV - Opportunities
Genomma Lab Internacional SAB de CV - Threats
Genomma Lab Internacional SAB de CV - Key Competitors

SECTION 3 – COMPANY FINANCIAL RATIOS

Financial Ratios - Capital Market Ratios
Financial Ratios - Annual Ratios
Performance Chart
Financial Performance
Financial Ratios - Interim Ratios
Financial Ratios - Ratio Charts

SECTION 4 – COMPANY’S LIFESCIENCES FINANCIAL DEALS AND ALLIANCES

Genomma Lab Internacional SAB de CV, Pharmaceuticals & Healthcare, Deals By Year, 2014 to YTD 2020
Genomma Lab Internacional SAB de CV, Pharmaceuticals & Healthcare, Deals By Type, 2014 to YTD 2020
Genomma Lab Internacional SAB de CV, Recent Deals Summary

SECTION 5 – COMPANY’S RECENT DEVELOPMENTS

Apr 22, 2020: Genomma Lab Internacional reports first quarter 2020 results
Feb 26, 2020: Genomma Lab reports fourth quarter & full year 2019 results
Oct 23, 2019: Genomma Lab internacional reports third quarter 2019 results
Sep 30, 2019: Genomma Lab Internacional Informs Total Prepayment Of Local Bond (CEBUR) LAB
Jul 24, 2019: Genomma Lab Internacional reports second quarter 2019 results
Apr 29, 2019: Genomma Lab Internacional reports first quarter 2019 results
Feb 26, 2019: Genomma Lab Internacional announces Fourth Quarter & Full Year 2018 Results

SECTION 6 – APPENDIX

Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

List Of Tables

LIST OF TABLES

Genomma Lab Internacional SAB de CV, Key Facts
Genomma Lab Internacional SAB de CV, Key Employees
Genomma Lab Internacional SAB de CV, Major Products and Services
Genomma Lab Internacional SAB de CV, History
Genomma Lab Internacional SAB de CV, Subsidiaries
Genomma Lab Internacional SAB de CV, Key Competitors
Genomma Lab Internacional SAB de CV, Ratios based on current share price
Genomma Lab Internacional SAB de CV, Annual Ratios
Genomma Lab Internacional SAB de CV, Annual Ratios (Cont...1)
Genomma Lab Internacional SAB de CV, Annual Ratios (Cont...2)
Genomma Lab Internacional SAB de CV, Interim Ratios
Genomma Lab Internacional SAB de CV, Pharmaceuticals & Healthcare, Deals By Year, 2014 to YTD 2020
Genomma Lab Internacional SAB de CV, Pharmaceuticals & Healthcare, Deals By Type, 2014 to YTD 2020
Genomma Lab Internacional SAB de CV, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

List Of Figures

LIST OF FIGURES

Genomma Lab Internacional SAB de CV, Performance Chart (2015 - 2019)
Genomma Lab Internacional SAB de CV, Ratio Charts
Genomma Lab Internacional SAB de CV, Pharmaceuticals & Healthcare, Deals By Year, 2014 to YTD 2020
Genomma Lab Internacional SAB de CV, Pharmaceuticals & Healthcare, Deals by Type, 2014 to YTD 2020

COMPANIES MENTIONED

Nucitec SA de CV
Atlantis Pharma SA de CV
Laboratorios Pisa SA De CV
Medica Sur SAB de CV
Laboratorios Grin SA de CV